Duquesne Family Office’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-489,626
Closed -$39.2M 56
2019
Q2
$39.2M Buy
489,626
+210,544
+75% +$16.1M 1.16% 28
2019
Q1
$22.1M Buy
+279,082
New +$20.9M 0.64% 32
2017
Q3
Sell
-791,764
Closed -$48.4M 43
2017
Q2
$48.4M Buy
+791,764
New +$48.2M 2.59% 13
2017
Q1
Sell
-716,622
Closed -$40.3M 57
2016
Q4
$40.3M Hold
716,622
3.92% 11
2016
Q3
$42.7M Buy
+716,622
New +$41.9M 3.77% 6
2014
Q4
Sell
-345,421
Closed -$19.5M 42
2014
Q3
$19.5M Buy
+345,421
New +$19.4M 2.4% 17

Other funds holding MRK

Duquesne Family Office's MRK Position: Q3 2019 in Review

Duquesne Family Office sold out of Merck (MRK) in Q3 2019, closing a stake of 489,626 shares — an estimated $39.2M sold.

Duquesne Family Office first reported a position in MRK in Q3 2014 and held it in 6 quarters. The position peaked at $48.4M in Q2 2017. 2,306 funds tracked by Wall St. Rank hold MRK as of Q3 2019.

  • Duquesne Family Office reported no remaining Merck position as of Q3 2019 after selling out during the quarter.
  • Duquesne Family Office sold 489,626 Merck shares in Q3 2019, an estimated $39.2M.
  • Duquesne Family Office first reported a position in Merck in Q3 2014 and held it in 6 quarters.
  • Duquesne Family Office's Merck position peaked at $48.4M in Q2 2017.
  • 2,306 funds tracked by Wall St. Rank held Merck as of Q3 2019.

Based on Duquesne Family Office's 13F filing for Q3 2019, filed 14 Nov 2019.